Concepedia

Author

Masaru Muraoka

University of YamanashiORCID

Also Known As

M Muraoka, M. Muraoka, M., Muraoka, Masaru MURAOKA, Masaru Muraoka

106

Publications

1.2K

Citations

17

H-Index

56

Concepts

All Affiliations

University of YamanashiTokyo Medical and Dental UniversityMusashino Red Cross HospitalUniversity of Yamanashi HospitalChugai Pharma (United States)
MM

About

Masaru Muraoka is an author at University of Yamanashi specializing in medicine, antibody engineering, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

164

2

Engineering

2

2

61

3

Health Sciences

2

2

23

4

Natural Sciences

1

1

24

5

Applied Physiology

1

1

10

Masaru Muraoka

×

24

Publications

1K

Citations

17

H-Index

YearCitations

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

Yasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura,

Hepatology

2013

247

Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIaR131 and FcγRIIaH131

Futa Mimoto, Hitoshi Katada, Shojiro Kadono,

Protein Engineering Design and Selection

2013

127

Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma

Kaoru Tsuchiya, Yasuhiro Asahina, Shuya Matsuda,

Cancer

2013

67

Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells.

Michiko Miyaki, K Tanaka, Rei Kikuchi-Yanoshita,

PubMed

1995

63

Association of Gene Expression Involving Innate Immunity and Genetic Variation in Interleukin 28B With Antiviral Response

Yasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka,

Hepatology

2011

57

Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody

Zenjiro Sampei, Kenta Haraya, Tatsuhiko Tachibana,

PLoS ONE

2018

56

Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients

Nobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda,

Journal of Gastroenterology

2013

51

Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma

Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu,

Hepatology Research

2018

49

Specific Protein Delivery to Target Cells by Antibody-displaying Bionanocapsules

Noriyuki Kurata, Takuya Shishido, Masaru Muraoka,

The Journal of Biochemistry

2008

38

Deep Sequencing and Phylogenetic Analysis of Variants Resistant to Interferon-Based Protease Inhibitor Therapy in Chronic Hepatitis Induced by Genotype 1b Hepatitis C Virus

Mitsuaki Sato, Shinya Maekawa, Nobutoshi Komatsu,

Journal of Virology

2015

31

Page 1